Cargando…
A Clinical Prediction Score Including Trial of Antibiotics and C-Reactive Protein to Improve the Diagnosis of Tuberculosis in Ambulatory People With HIV
BACKGROUND: The use of a “trial of antibiotics” as empiric therapy for bacterial pneumonia as a diagnostic tool for tuberculosis in people with HIV (PWH) was removed from World Health Organization (WHO) recommendations in 2007, based on expert opinion. Current guidelines recommend antibiotics only a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000838/ https://www.ncbi.nlm.nih.gov/pubmed/32042850 http://dx.doi.org/10.1093/ofid/ofz543 |
_version_ | 1783494121286008832 |
---|---|
author | Boyles, Tom H Nduna, Matilda Pitsi, Thalitha Scott, Lesley Fox, Matthew P Maartens, Gary |
author_facet | Boyles, Tom H Nduna, Matilda Pitsi, Thalitha Scott, Lesley Fox, Matthew P Maartens, Gary |
author_sort | Boyles, Tom H |
collection | PubMed |
description | BACKGROUND: The use of a “trial of antibiotics” as empiric therapy for bacterial pneumonia as a diagnostic tool for tuberculosis in people with HIV (PWH) was removed from World Health Organization (WHO) recommendations in 2007, based on expert opinion. Current guidelines recommend antibiotics only after 2 Xpert MTB/RIF tests (if available), chest x-ray, and clinical assessment have suggested that tuberculosis is unlikely. Despite this, a “trial of antibiotics” remains common in algorithms in low-resource settings, but its value is uncertain. C-reactive protein (CRP), which has been proposed as a “rule-out” test for tuberculosis, may be an objective marker of response to antibiotics. METHODS: We performed a passive case-finding cohort study of adult PWH with a positive WHO symptom screen. All participants received antibiotics at first visit according to the local protocol and were reviewed to ascertain clinical response. Point-of-care CRP was measured at both visits. All patients had sputum tested with Xpert MTB/RIF Ultra (Ultra), and the reference standard was based on 2 sputum mycobacterial cultures. We explored multivariable prediction models (MPM) for tuberculosis based on 1 or 2 visits. RESULTS: Seventy-five of 207 patients (36%) had confirmed tuberculosis. Clinical response to antibiotics after 2 days was a good predictor of disease. An MPM based on 2 visits, without CRP, had acceptable discrimination (c-statistic, 0.75) and calibration (goodness-of-fit P = .07). Addition of CRP after antibiotics improved the model moderately (c-statistic, 0.78). CRP at first visit was not an independent predictor of tuberculosis. CONCLUSIONS: In adult PWH seeking care for symptoms suggestive of tuberculosis, lack of response to antibiotics is a strong predictor of disease and is likely to be useful, particularly when access to Ultra is limited. CRP adds value when measured after antibiotics but is of limited value at first visit. |
format | Online Article Text |
id | pubmed-7000838 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-70008382020-02-10 A Clinical Prediction Score Including Trial of Antibiotics and C-Reactive Protein to Improve the Diagnosis of Tuberculosis in Ambulatory People With HIV Boyles, Tom H Nduna, Matilda Pitsi, Thalitha Scott, Lesley Fox, Matthew P Maartens, Gary Open Forum Infect Dis Major Article BACKGROUND: The use of a “trial of antibiotics” as empiric therapy for bacterial pneumonia as a diagnostic tool for tuberculosis in people with HIV (PWH) was removed from World Health Organization (WHO) recommendations in 2007, based on expert opinion. Current guidelines recommend antibiotics only after 2 Xpert MTB/RIF tests (if available), chest x-ray, and clinical assessment have suggested that tuberculosis is unlikely. Despite this, a “trial of antibiotics” remains common in algorithms in low-resource settings, but its value is uncertain. C-reactive protein (CRP), which has been proposed as a “rule-out” test for tuberculosis, may be an objective marker of response to antibiotics. METHODS: We performed a passive case-finding cohort study of adult PWH with a positive WHO symptom screen. All participants received antibiotics at first visit according to the local protocol and were reviewed to ascertain clinical response. Point-of-care CRP was measured at both visits. All patients had sputum tested with Xpert MTB/RIF Ultra (Ultra), and the reference standard was based on 2 sputum mycobacterial cultures. We explored multivariable prediction models (MPM) for tuberculosis based on 1 or 2 visits. RESULTS: Seventy-five of 207 patients (36%) had confirmed tuberculosis. Clinical response to antibiotics after 2 days was a good predictor of disease. An MPM based on 2 visits, without CRP, had acceptable discrimination (c-statistic, 0.75) and calibration (goodness-of-fit P = .07). Addition of CRP after antibiotics improved the model moderately (c-statistic, 0.78). CRP at first visit was not an independent predictor of tuberculosis. CONCLUSIONS: In adult PWH seeking care for symptoms suggestive of tuberculosis, lack of response to antibiotics is a strong predictor of disease and is likely to be useful, particularly when access to Ultra is limited. CRP adds value when measured after antibiotics but is of limited value at first visit. Oxford University Press 2020-01-06 /pmc/articles/PMC7000838/ /pubmed/32042850 http://dx.doi.org/10.1093/ofid/ofz543 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Major Article Boyles, Tom H Nduna, Matilda Pitsi, Thalitha Scott, Lesley Fox, Matthew P Maartens, Gary A Clinical Prediction Score Including Trial of Antibiotics and C-Reactive Protein to Improve the Diagnosis of Tuberculosis in Ambulatory People With HIV |
title | A Clinical Prediction Score Including Trial of Antibiotics and C-Reactive Protein to Improve the Diagnosis of Tuberculosis in Ambulatory People With HIV |
title_full | A Clinical Prediction Score Including Trial of Antibiotics and C-Reactive Protein to Improve the Diagnosis of Tuberculosis in Ambulatory People With HIV |
title_fullStr | A Clinical Prediction Score Including Trial of Antibiotics and C-Reactive Protein to Improve the Diagnosis of Tuberculosis in Ambulatory People With HIV |
title_full_unstemmed | A Clinical Prediction Score Including Trial of Antibiotics and C-Reactive Protein to Improve the Diagnosis of Tuberculosis in Ambulatory People With HIV |
title_short | A Clinical Prediction Score Including Trial of Antibiotics and C-Reactive Protein to Improve the Diagnosis of Tuberculosis in Ambulatory People With HIV |
title_sort | clinical prediction score including trial of antibiotics and c-reactive protein to improve the diagnosis of tuberculosis in ambulatory people with hiv |
topic | Major Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000838/ https://www.ncbi.nlm.nih.gov/pubmed/32042850 http://dx.doi.org/10.1093/ofid/ofz543 |
work_keys_str_mv | AT boylestomh aclinicalpredictionscoreincludingtrialofantibioticsandcreactiveproteintoimprovethediagnosisoftuberculosisinambulatorypeoplewithhiv AT ndunamatilda aclinicalpredictionscoreincludingtrialofantibioticsandcreactiveproteintoimprovethediagnosisoftuberculosisinambulatorypeoplewithhiv AT pitsithalitha aclinicalpredictionscoreincludingtrialofantibioticsandcreactiveproteintoimprovethediagnosisoftuberculosisinambulatorypeoplewithhiv AT scottlesley aclinicalpredictionscoreincludingtrialofantibioticsandcreactiveproteintoimprovethediagnosisoftuberculosisinambulatorypeoplewithhiv AT foxmatthewp aclinicalpredictionscoreincludingtrialofantibioticsandcreactiveproteintoimprovethediagnosisoftuberculosisinambulatorypeoplewithhiv AT maartensgary aclinicalpredictionscoreincludingtrialofantibioticsandcreactiveproteintoimprovethediagnosisoftuberculosisinambulatorypeoplewithhiv AT boylestomh clinicalpredictionscoreincludingtrialofantibioticsandcreactiveproteintoimprovethediagnosisoftuberculosisinambulatorypeoplewithhiv AT ndunamatilda clinicalpredictionscoreincludingtrialofantibioticsandcreactiveproteintoimprovethediagnosisoftuberculosisinambulatorypeoplewithhiv AT pitsithalitha clinicalpredictionscoreincludingtrialofantibioticsandcreactiveproteintoimprovethediagnosisoftuberculosisinambulatorypeoplewithhiv AT scottlesley clinicalpredictionscoreincludingtrialofantibioticsandcreactiveproteintoimprovethediagnosisoftuberculosisinambulatorypeoplewithhiv AT foxmatthewp clinicalpredictionscoreincludingtrialofantibioticsandcreactiveproteintoimprovethediagnosisoftuberculosisinambulatorypeoplewithhiv AT maartensgary clinicalpredictionscoreincludingtrialofantibioticsandcreactiveproteintoimprovethediagnosisoftuberculosisinambulatorypeoplewithhiv |